Guangdong Biolight Meditech Co., Ltd.
CN¥12.02-CN¥0.25 (-2.04%)
Guangdong Biolight Meditech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.31% below the high.
SHH · 688067.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
AVE Science&Technology CO.,LTD’s quoted price sits in the lower half of its reported 52-week range, 33.31% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
AVE Science&Technology CO.,LTD’s forward annual dividend is CN¥0.20 per share, paid semi-annual. The forward yield is 1.01% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow AVE Science&Technology CO.,LTD’s reporting calendar.
THE COMPANY BEHIND THE TICKER
AVE Science&Technology CO.,LTD operates comprehensively in the medical technology sector, engaging in the full spectrum of activities from initial research and development to manufacturing, sales, and post-sale support. Its diverse portfolio includes medical devices, biological reagents, remote medical diagnostic networks, specialized computer software, automated control systems, and various medical auxiliary equipment. The company's product offerings prominently feature advanced diagnostic instruments, such as analyzers for urine formed elements (along with their associated reagents), automated urine analysis systems, multi-functional microscopy devices, semi-automatic biochemical analyzers, and feces analyzers. Complementing these devices, AVE Science&Technology also supplies essential consumables, including reagent kits, quality control solutions for analyzers, test strips, and cleaning agents. Serving a global clientele, the company's reach extends across Europe, the United States, Asia, and Africa. Established in 2000, AVE Science&Technology CO.,LTD is headquartered in Changsha, China. The organization transitioned to its present name in September 2012, having previously been known as Changsha High - tech Industrial Development Zone Aiwei Technology Industrial Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:30 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
CN¥12.02-CN¥0.25 (-2.04%)
Guangdong Biolight Meditech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.31% below the high.
CN¥22.64-CN¥0.48 (-2.08%)
Guangzhou Jet Bio-Filtration Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 25.96% below the high.
CN¥28.45-CN¥1.46 (-4.88%)
Shaanxi Kanghui Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.36% below the high.
CN¥7.31+CN¥1.22 (+20.03%)
Improve Medical Instruments Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.78% below the high.
CN¥7.70-CN¥0.16 (-2.04%)
Jiangsu Nanfang Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.89% below the high.
CN¥17.19-CN¥1.05 (-5.76%)
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.11% below the high.
CN¥17.57-CN¥1.00 (-5.39%)
Guangzhou LBP Medicine Science & Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.9% below the high.
CN¥11.85-CN¥0.56 (-4.51%)
Jiangsu gdk Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 62.02% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.